Booth Healthcare conference 2018

Sponsored by BlueCross BlueShield of Illinois

2017-2018

FRIDAY, november 9, 2018

8:00 am - 5:00 pm

University Club of Chicago

76 E Monroe St, Chicago, IL 60603


The Power of Personalization: Why Customization is Key to Consumer-Centric Healthcare

Healthcare is being increasingly driven by technology and becoming better suited to the individualized needs of health consumers. A one-size-fits all approach is being replaced by increasingly personalized options. This year’s conference will focus on trends in personalization in healthcare and explore how new technologies and care delivery methods can improve care.

Conference participants from across the country will join in discussing these topics for a full-day conference and networking event.

Tickets can be purchased HERE.


schedule of events

8:00-9:00 am: Registration and Breakfast

9:00-9:15 am: Welcome Address

9:15-10:15 am: Opening Keynote

10:15-10:35 am: Break

10:35-11:35 am: Concurrent Panels

Panel A | Senior-Centered Care: Preparing Personalized Health Interventions for the Silver Tsunami in Aging America

Panel B | Investing in Individuals: The Business Case for Personalization

11:35-11:45 am: Break

11:45 am-12:45 pm: Lunch & Start-Up Fair

12:45-1:45 pm: Lunch Keynote

1:45-2:00 pm: Break

2:00-3:00 pm: Concurrent Panels

Panel A | Personalizing Behavioral Health Interventions

Panel B | Precision Medicine: Better Quality, But at What Cost?

3:00-3:10 pm: Break

3:10-4:10 pm: Closing keynote

4:10-5:00 pm: Networking Reception Sponsored by Deloitte

thank you to our sponsors



SPEAKERS (SUbject to change)

WELCOME ADDRESS

Madhav Rajan, Dean and George Pratt Shultz Professor of Accounting at Chicago Booth

Madhav Rajan joined the Chicago Booth faculty on July 1, 2017, as Dean and George Pratt Shultz Professor of Accounting. Before joining Booth, Rajan spent 16 years on the faculty of the Stanford University Graduate School of Business where he was the Robert K. Jaedicke Professor of Accounting, with a courtesy appointment in the Law School. He served as senior associate dean for academic affairs from 2010-2016, overseeing the school’s MBA program. From 2002-2010, he was area coordinator for the accounting faculty group. Previously, he served on the faculty at the Wharton School of the University of Pennsylvania, from 1990-2001.

While at Stanford, Rajan received the Robert T. Davis Award for Lifetime Achievement and Service (2017), and the Notable Contribution to Management Accounting Literature Award (2004). He also was the recipient of the David W. Hauck Award for Outstanding Teaching at Wharton (2000) and the Alexander Henderson Award for Excellence in Economic Theory (1990).

KEYNOTE PRESENTATIONS

Opening Keynote Speaker:

Jeffrey Bennett, CEO of higi

Jeff Bennett is CEO of higi, a population health enablement company making it easier for consumers to be their healthiest by providing accessible, affordable and convenient connected care and digital navigation solutions. higi’s solutions empower consumers to measure, track and act on their health data by making it seamless to share it with their trusted care professionals. This allows these care professionals and at-risk healthcare organizations to better reach, know and manage their populations to achieve better health. Prior to joining higi, Bennett served as the Managing Director for Merrick Ventures. There, he led and managed the day-to-day operations and acted as strategic advisor for portfolio companies, including Merge Healthcare, leading corporate business development prior to its acquisition by IBM. With a strong passion and a personal connection to chronic disease management and preventative healthcare, Bennett immediately saw the vision and potential in higi and joined in July 2013 as CEO.

Lunch Keynote Speaker:

Rob Scott, MD, Chief Medical Officer, VP Global Development at AbbVie

Rob Scott is Zimbabwean born and studied medicine at the University of Cape Town. For the past 30 years, Rob has held leadership positions in global pharmaceutical companies and since 2016 has led AbbVie’s global Development team while also serving as the Chief Medical Officer. A leader in the digital transformation of clinical research, Rob opened AbbVie’s Development Design Center in 2018 to help teams use predictive analytics for designing and implementing clinical trials.

Prior to AbbVie, he was involved in the development of Lipitor and Norvasc at Pfizer, he designed and implemented the first large cardiovascular outcomes study to be wholly performed by a small biotech at AtheroGenics and conducted the first outcome study for a PCSK9i at Amgen. Between 2012 and 2016, he was a member of the FDA Cardiac and Renal Drug Advisory Committee and has also served on the Endocrine and Metabolic Advisory Committee. Throughout this career, Rob has been involved with every therapeutic area and mode of drug delivery as well as both small molecules and biologics and invented and developed the first drug combination to simultaneously treat two different disease states.

Lunch Keynote Moderator:

Steven Collens, CEO of MATTER

Steven Collens is CEO of MATTER, the healthcare technology incubator and innovation center. MATTER opened in February 2015 and nurtures entrepreneurs and innovators building next-generation health IT, medical device, diagnostic and biopharma technologies. MATTER works with 200 healthcare technology ventures and the company partners with 10 hospitals and health systems, five universities and more than 50 industry-leading companies. Steven is also senior advisor at Pritzker Group Venture Capital.

Prior to assuming his current role, Steven was senior vice president at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In that capacity, he led the team that created 1871, Chicago’s center for digital startups that now houses more than 400 early-stage companies. He previously worked at Abbott in a variety of domestic and international functions, including product management, policy and public affairs. In 2005, Steven helped found ConstantWellness.com to give patients control over their health data and allow healthcare providers to coordinate care of their patients. Prior to Abbott, Steven served as legislative assistant to U.S. Senator Carol Moseley-Braun.

Steven holds an MBA from Northwestern University’s Kellogg School of Management and a BA from Washington University in St. Louis. He serves on the boards of 1871, the Ann & Robert H. Lurie Children’s Hospital of Chicago, the Chicago High School for the Arts and Hubbard Street Dance Chicago. He is also a Leadership Greater Chicago fellow and a member of the Economic Club of Chicago and the Commercial Club of Chicago.

Closing Keynote Speaker:

Kaveh Safavi, MD, JD, Senior Global Managing Director, Head of Global Health Practice at Accenture

Kaveh Safavi, M.D., J.D. is the senior managing director and head of Accenture’s global healthcare practice. Dr. Safavi is responsible for developing and driving a growth strategy that differentiates Accenture’s healthcare offerings for providers, health insurers and public and private health systems across the globe.

As a seasoned executive, Dr. Safavi brings more than three decades of leadership experience to Accenture’s health practice. He joined Accenture from Cisco, in 2011, where he led the global healthcare practice and has served in leadership roles at Thompson Reuters, United Healthcare, HealthSpring and Humana. His accomplishments include establishing one of the Midwest’s first electronic health record-enabled primary care practices. Dr. Safavi currently serves as a member of the board of directors for Xcertia, which supports industry guidelines for safe and effective mobile health apps, and also serves on the advisory committee of the Buck Institute for Research on Aging.

Closing Keynote Moderator:

Michael L. Millenson, President, Health Quality Advisors LLC, Highland Park, IL and adjunct associate professor of medicine, Feinberg School of Medicine, Northwestern University

Michael L. Millenson, author of the critically acclaimed book, Demanding Medical Excellence: Doctors and Accountability in the Information Age, is an internationally recognized expert on making health care better, safer and more patient-centered. His research, consulting and writing include a case study on accountability for the Harvard Business School and examining the evidence behind direct-to-consumer diagnostic apps. Michael heads his own consulting firm, Health Quality Advisors, is deeply involved in health policy and is an adjunct associate professor at Northwestern University’s Feinberg School of Medicine. He’s lectured at the National Institutes of Health, testified before Congress and served as an advisor to a number of start-ups. Michael serves on the board of Project Patient Care and has written for publications ranging from the BMJ to The Washington Post. Earlier in his career, he was nominated for a Pulitzer Prize three times as a reporter for the Chicago Tribune.


PANELS

PANEL 1: Senior-Centered Care: Preparing Personalized Health Interventions for the Silver Tsunami in Aging America

Benjamin Berk, MD, CEO, Attuned Care

Dr. Benjamin Berk is an experienced health care executive with a background as a medical doctor, information technologist, and business manager. Benjamin is CEO of Attuned Care, which provides coordinated care for residents of senior communities. Previously, Benjamin was VP Population Health at Iora Health, serving as business lead for Iora's Medicare Advantage and risk-contract practices, and a Principal at the Boston Consulting Group (BCG), where he was global coordinator for health care IT. He has been an independent consultant and an adviser to Oliver Wyman, working with health systems and startups in the US and the UK. Benjamin is an Adjunct Instructor at The Dartmouth Institute for Health Policy and Clinical Practice. Benjamin received his Medical Doctorate and Masters in Management Science and Engineering from Stanford and his BA in Information Age Studies from Dartmouth College.

David Jacobs, Managing Director, 7wire Ventures

David Jacobs is a Managing Director at 7wire Ventures with 15 years of healthcare experience. Formerly, he served as the President of Post Acute Care and the DME Division at Medline Industries. In addition, David is the founder of Inc. 500 businesses and a brand manager for Quaker Oats. Mr. Jacobs is a board member of Land O Frost – a mid-size, family owned private company. Mr. Jacobs has a B.A. from Yale University and an MBA from Northwestern/Kellogg. He is married for 18 years with 2 children.

Griffin Myers, MD '07, MBA '10, Co-Founder and Chief Medical Officer at Oak Street Health

Dr. Griffin Myers is Cofounder and Chief Medical Officer at Oak Street Health, a growing organization of value-based primary care centers serving adults on Medicare headquartered in Chicago. Prior to Oak Street Health, Dr. Myers did his residency in emergency medicine at Harvard Medical School, namely the Brigham and Women’s and Massachusetts General Hospitals. Dr. Myers is B.S. graduate of Davidson College, has an M.B.A. from the University of Chicago Booth School of Business, and has an M.D. from the University of Chicago Pritzker School of Medicine. He is a fellow of the American College of Emergency Physicians, an Adjunct Instructor of Emergency Medicine at Northwestern University’s Feinberg School of Medicine, a Thought Leader for the New England Journal of Medicine Catalyst, a Presidential Leadership Scholar, and an Aspen Health Innovators Fellow. Dr. Myers lives in Jackson, Wyoming with his wife, Diana, and dog, Cruz.

Leslie Basham, President and Chief Operating Officer at Surgical Directions

Leslie is the President and COO of Surgical Directions, a leading perioperative and healthcare consulting company. Surgical Directions’ multi-disciplinary team of clinical, analytic, and strategy experts have successfully helped over 400 hospitals nationally improve patient outcomes, increase staff and patient engagement, reduce cost, and enhance organization profitability.Leslie is passionate about partnering with healthcare executives to improve the health and wellbeing of the communities they serve, while profitably growing their organizations. She has regularly published and presented on Health transformations.

Prior to joining Surgical Directions, Leslie was an executive in Accenture’s Health Strategy Practice, co-leading the patient access and health consumer offerings. She also worked in investment banking, FP&A and process improvement. She has her MBA from Kellogg School of Management and BSBA from Washington University in St. Louis. She is married with three wonderful children, and lives in Chicago.

Mike Suwalski, Director of Medicare Operations at Walgreens

Mike Suwalski is a passionate, results-oriented healthcare executive with a strong, diverse background in pharmacy, business operations, product development, and people management. Mike led many strategic programs for Walgreens during his 36 year career. His previous roles included Director of Medicare Operations, Sr. Director of Product Innovation, National Director of Onsite Operations, Manager of Pharmacy Systems, Manager of Quality Assurance, Director of Pharmacy School Relations and Clinical Education, along with several field operation positions. Some of Mike’s key accomplishments included helping seniors through Medicare Operations, launching the 90-day at Retail program, developing a National Cash Pricing Strategy, creating a Patented Continuous Quality Improvement Platform, and transforming Walgreens’ Traditional Retail Operating Model into a model - which allowed for expansion into hospitals, work places, communities, and doctor’s offices. Mike earned his undergrad and pharmacy degree from the University of Illinois at Chicago.

Moderator: Mark Bourdenko, '15, Engagement Manager at The Chartis Group

Mark Bourdenko is an Engagement Manager with The Chartis Group. At Chartis, he has advised health systems on topics such as post-acute care and long term senior services, primary care strategy, and payor-provider partnerships. Most recently, Mark worked with a premier senior services provider to develop a five-year business plan in the context of a rapidly evolving market.

Prior to joining The Chartis Group, Mark worked in primary education. He co-founded and co-designed a math tutoring program serving 480 students across 4 high poverty turnaround schools. The site he managed outperformed all schools in a 26-school network, with student math ability growing on average by 1.9 grade levels over a 1 year period. Mr. Bourdenko holds a Master of Business Administration from the University of Chicago Booth School of Business. He received a Bachelor of Arts with General Honors in Economics and Political Science from the University of Chicago.


PANEL 2: Investing in Individuals: The Business Case for Personalization

Alyssa Jaffee, MBA'16, Investor at Pritzker Group Venture Capital

Alyssa Jaffee is an investor at the Pritzker Group Venture Capital where she focuses on digital health. She is currently a board observer for Apervita, AiCure, Eved, Bright.md, Tovala, and SilverVue. Alyssa was also the co-founder of TransparentCareer, 2016 New Venture Challenge winning company focused on helping people make more data-driven career decisions. Alyssa’s prior experience in venture capital includes time at Hyde Park Angels (HPA), one of the Midwest's largest angel organizations as well as Healthbox, an early stage healthcare innovation firm, supporting their accelerator program called the Studio.

Prior to business school, Alyssa worked as the Senior Director of Performance Technologies for the Advisory Board Company. There, Alyssa was charged with expanding new business through the sales of technology platforms. With an extensive travel regimen, Alyssa met with hundreds of hospital executive teams to understand their strategic needs and recommend various solutions. She has copious amounts of experience in launching new products and thinking about go-to-market strategies. Alyssa holds a bachelor degree with honors in Marketing and Spanish from the University of Wisconsin-Madison and an M.B.A. from the University of Chicago – Booth School of Business.

Binoy Bhansali, Vice President at Sandbox Industries

Binoy helps manage the Fund’s investments in Healthify, ExactCare, Payfone, Wellspring, and Swipesense. Prior to joining Sandbox, Binoy was a consultant at Accenture advising healthcare organizations on mergers and acquisitions while also working part-time at a social impact investment firm, Impact Investment Partners. Binoy started his career at Citibank in its investment banking group where he worked primarily within the hospital sector. Binoy holds a BA in Economics and a BA in Psychology from Northwestern University. He is a member of the Kauffman Fellows Program, Class 23.

Dan Liljenquist, Senior Vice President - Chief Strategy Officer, Enterprise Initiative Office, Intermountain Healthcare

Dan Liljenquist is a Senior Vice President and Chief Strategy Officer for Intermountain Healthcare. Prior to joining Intermountain in 2012, Dan served in the Utah State Senate and was the President of Focus Services, LLC a business process services company with over 2,000 employees. He is a former strategy consultant with Bain & Company, Inc.

Dan is the lead architect of Project Rx, an initiative to create a not-for-profit generic drug company to “ensure that essential generic medications are available and affordable to everyone”. Dan received his Juris Doctorate from The University of Chicago Law School and his Bachelor of Arts in Economics from Brigham Young University. Dan and his wife, Brooke, are the parents of six children and reside in Bountiful, Utah.

Mary Tolan, MBA'92, Founder and Co-Managing Partner, Chicago Pacific Founders

Mary is Founder and Co-Managing Partner of Chicago Pacific Founders, a healthcare private equity firm. Previously, she was Founder, Chairman and CEO of Accretive Health, a healthcare technology services company and took Accretive public in 2010 ($1.2b). Mary was a Group Chief Executive at Accenture, a $16 billion global technology services company and took Accenture public in 2001 ($14b). She has received several honors and awards, including being named to Crain’s “Top 40 Under 40” list, the Ernst and Young Entrepreneur of the Year in Services 2010 Award, the Distinguished Alumnus University of Chicago and the Illinois Venture Capital Company of the Year Award. She is a Trustee of the University of Chicago. She received a BA from Loyola University in 1982, and an MBA from the University of Chicago in 1992.

Sharon Langshur, MD, Chief Operating Officer at Abundant Venture Partners

Sharon Langshur, M.D. joined Abundant Venture Partners at the time of its founding in 2011, with an extensive background in early stage healthcare and technology businesses. She currently serves as COO, overseeing holding company functions and engaging with portfolio companies in operating and governance roles. Prior to joining Abundant Venture Partners, Dr. Langshur worked closely with many early stage businesses providing administrative, strategic and financial support. In 2000, she co-founded CarePages, Inc., which connected patients and families with their extended support community during prolonged illness and hospitalization via a communication platform. She functioned in many different roles until its acquisition in 2007 by Revolution Health.

Before CarePages, Dr. Langshur was a physician undergoing pediatric residency training at Northwestern University. Her medical training was completed at the University of Connecticut and she holds an M.S. in Human Genetics from Sarah Lawrence College and a B.Sc. from McGill University.

Rafael Torres, Senior Vice President, Business Development and Strategy at Varian Medical Systems

Rafael Torres joined Varian in May 2015, as senior vice president for business development and strategy. In this role, he leads the company's strategic plans for growth through acquisitions, investments, and partnerships that complement our current portfolio of businesses. Prior to joining Varian, Mr. Torres, served as global head of healthcare for GE Ventures and GE Equity, where he built a strategic investments portfolio of over 30 healthcare companies. He was a founding member of GE Ventures and a member of its senior leadership committee. Mr. Torres led the healthcare investment team, and represented GE on portfolio company boards, including CardioDx, InSightec, LipoScience, Navinet and ParadigmHealth.

Mr. Torres was a judge of the healthymagination Cancer Innovation Challenge and a member of the StartupHealth transformers advisory panel. He has been featured in healthcare publications and conferences including The Gray Sheet, MedDevice Daily, SXSW, Slush Digital Health and Biomed Israel. Previous to that, he worked for The Boston Consulting Group and Citibank N.A. He holds an MBA degree from Harvard Business School and a B.A. in economics from the Universidad del Pacifico in Lima, Peru.

Moderator: Holly Tu, MBA'18, Vice President at Chicago Pacific Founders

Holly Tu is the Vice President of De Novo Growth Operations at Chicago Pacific Founders. She is building a capability across the fund that helps portfolio companies scale through de novo growth. Prior to Chicago Pacific Founders, Holly was with Accenture’s Strategy Consulting practice in San Francisco. She worked with health systems and payors on enterprise transformations and growth strategy. She also worked at Doctor On Demand, one of the largest providers of primary care and behavioral health care video visits in the US.

Holly has her MBA from University of Chicago’s Booth School of Business, and her BA from UC Berkeley. She earned her certification in healthcare administration from the Graduate Program in Healthcare Administration and Policy (GPHAP) at the University of Chicago.


PANEL 3: Personalizing Behavioral Health Interventions

Dan Clark, CEO & President at Ieso Digital Health

Dan has a rich background in behavioral health. He is a mental health counselor by training and has not only started two successful, technology-enabled healthcare service businesses, but has also led the scaling, innovation and growth of companies ranging from smaller seed-stage companies to major Fortune 50 organizations. Dan has held senior executive roles at OPTUM Health, Humana, Aetna, Cigna, and Value Options (now Beacon Health Options) and has extensive experience in managed behavioral health, wellness, population health services, general healthcare and group insurances across several markets including Medicare, Medicaid, Commercial, Payer and Provider groups.

Stephen Smith, Founder & CEO at NOCD

Stephen Smith is the founder and CEO of NOCD, a mobile platform that helps people with obsessive-compulsive disorder (OCD) manage their care 24/7 and connect with others who understand them. Under his leadership, NOCD has amassed a community of over 80,000 active community members, making NOCD the the world’s largest OCD treatment community today. Stephen’s focused on delivering people with OCD multi-tiered care, that helps them engage in a continuum of online support from one’s self, community, and clinician, in order to prevent severe, costly comorbidities from developing, such as major depressive disorder and substance use disorder. Stephen received a Bachelor of Arts from Pomona College in Chinese and Economics. He was also an NCAA quarterback for four years.

Matty Francis, MBA'11, Director, Innovation Consulting at Healthbox

Matty leads Healthbox's innovation consulting practice. Prior to Healthbox, Matty held leadership roles at North Fork Ventures, Groupon, and Bank of America Merrill Lynch, focusing on strategic planning and corporate finance. Additionally, he supported consulting engagements for healthcare providers while at Sg2. Matty holds a BS in Biomedical Engineering from the Northwestern University, where he currently sits on the department's Advisory Board, as well as an MBA from Chicago Booth. Additionally, he holds a CFA Charter.

Matthew C. Smith, PhD, Founding team member and former VP at Pear Therapeutics

Matthew is a scientist, strategic consultant, and life science executive. Some of his most recent activities have been with Pear Therapeutics as both a member of the founding team and its first Vice President. During his tenure leading Pear’s operations, Matthew helped build the company from inception through to commercialization of its first product reSET® for the treatment of Substance Use Disorder. reSET has the distinction of being the first ever FDA-cleared software product for the treatment of a disease. Matthew continues to provide strategic support for Pear and is an active advocate for digital therapeutics, in general. He now also spends a significant amount of his time helping to launch new, innovative, neuroscience-based biotech startups out of the University of Chicago.

Moderator: Rachael Mazzella, MBA'18, Consultant at Bain&Co.

Since graduating from Booth in 2018, Rachael has joined Bain&Company as a Consultant. She currently working on a strategy project for a pharmaceutical company new drug launch, and plans to continue building her knowledge about different players in the healthcare space. Before Booth, Rachael worked at Beacon Health Options (a behavioral health managed care organization based in Boston) and at Bain&Company as an Associate Consultant. She has also interned at Boston Children's Hospital's digital health accelerator and at Sandbox venture fund.


PANEL 4: Precision Medicine: Better Quality, But at What Cost?

Derek Robinson, MD, MBA'07, FACEP, CHCQM, Vice President and Chief Medical Officer at HCHS, Blue Cross Blue Shield

Dr. Derek J. Robinson is vice president and chief medical officer for Blue Cross and Blue Shield of Illinois (BCBSIL), a division of Health Care Service Corporation (HCSC). In this role, Dr. Robinson provides clinical leadership and strategic oversight to help ensure effective and efficient delivery of quality medical care to more than 8.5 million health plan members. Dr. Robinson also serves as the chair of HCSC’s Health Equity Steering Committee, which is responsible for the development and implementation of the company’s health equity strategy, including institutionalizing equity across the company’s business operations in five states. In his prior role, Dr. Robinson served as Vice President - Enterprise Quality and Accreditation at HCSC, the nation’s largest non-investor owned health insurer, serving more than 15 million members.

Dr. Robinson is board certified in Emergency Medicine and holds degrees from Xavier University of Louisiana, Howard University College of Medicine, and the University of Chicago Booth School of Business.

Jonas De Souza, MD, MBA, Medical Director, Office of the Chief Medical Officer, Humana

Jonas is a physician executive trained in internal medicine and oncology. He obtained his MBA from University of Chicago Booth School of Business in 2016. His passion for aligning the business and clinical aspects of medicine brought him to Humana in 2017 through the Executive Physician Immersion Program. In his current role, Jonas is responsible for delivering projects and insights to core business areas require credible business and clinical perspectives, such as strategy, marketing, innovation, operations and retail marketplace. Prior to Humana, Jonas was a faculty member of the University of Chicago, specializing in oncology. While in academia, Jonas focused his research on value-based initiatives and patient-centered outcomes, including the financial burden cancer patients experience due to the cost of their treatments.

Haibo Lu, MBA'14, Co-Founder at CancerIQ

Haibo is the cofounder and VP of Product and Customer Success at CancerIQ. CancerIQ is a digital healthcare solution that streamlines genetic cancer risk assessment and helps practices run a cancer high risk program. In this role, he oversees all product development and management as well as implementation and execution of the CancerIQ application into clinical workflow. Prior to CancerIQ, Haibo was the Director of Basketball Operations at the Shanghai Sharks – a professional basketball team in the CBA as well as the head analyst for the Chinese Men’s National Basketball Team. He has also worked as a quantitative research analyst at AQR Capital Management. Haibo did his undergrad at Harvard University where he majored in economics and got his MBA from the University of Chicago Booth School of Business.

Sundeep Nayak, MD, Radiologist at Kaiser Permanente

Sundeep M Nayak, M.D. is a radiologist and senior physician in the San Francisco Bay Area with The Permanente Medical Group. He’s passionate about the multidisciplinary management of cancers of the brain and chest, operates as Regional Chair of the Imaging Appropriateness Committee and Lead Radiologist for Lung Cancer Screening for Northern California, and serves on the Inter-Regional Clinical Practice Guidelines Committee for Radiology. Dr. Nayak actively engages in trainee education as Visiting Lecturer at the University of Chicago Pritzker School of Medicine, University of Chicago Booth School of Business, the American College of Radiology, the Society of Nuclear Medicine, and the International Atomic Energy Agency. Dr. Nayak has worked in both federal (VA; European Regional Medical Command) and fee-for-service economies and participated as Distinguished Visiting Surgeon for the American Red Cross. His interests are in molecular profiling of tumors, lung cancer screening, and applying deep learning to the healthcare space.

Peggy Hawkins, JD, Director, Business Development at Amgen

Peggy has a BS from the University of Michigan and a JD from the University of Washington School of Law. She spent the first half of her career in pharmaceutical R&D with Parke-Davis, Pfizer and Baxter Healthcare before attending law school. As an attorney, she practiced technology licensing and FDA law in the Pacific Northwest where she served biotech and medical device clients. She returned to the healthcare industry in a business development role with device firms Hologic and diaDexus. Most recently she was with Santen Pharmaceuticals where she worked on a number of device and drug related transactions and investments through their venture fund including the acquisition of the medical device company, InnFocus. She is now a Director in Business Development at Amgen where she focuses on licensing of early stage technologies which often includes complex partnering and investment transactions.

Moderator: Arun Bhatia, MBA'06, Sr. Director of Programs at Matter

Arun has a deep passion for the design and strategic growth of new healthcare and life-science ventures. Arun currently serves as Sr. Program Director for MATTER, a healthcare & life science technology incubator in Chicago serving over 200 start-up companies and 70 industry partners. He has held multi-faceted roles related to early-stage venture development including innovation strategy design and leading the intra-preneurship program at Baxter Healthcare, corporate venture evaluation and investing through Baxter Ventures, and university-stage start-up development and investment at IllinoisVENTURES. Arun’s passion for healthcare innovation was fostered through an MBA in Strategy and Entrepreneurship from the University of Chicago Booth School of Business as well as an MS in biotechnology from the Illinois Institute of Technology.